Yes, changes in manufacturing processes are closely scrutinized during drug quality audits in Japan. Regulatory authorities, such as the Pharmaceuticals and Medical Devices Agency (PMDA), ensure compliance with Good Manufacturing Practices (GMP). Any modifications must be documented, validated, and approved to maintain product quality and safety standards, ensuring public health protection.
